PMID: 11907352Mar 22, 2002Paper

Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer

Journal of Clinical Gastroenterology
Masahiko ShibataMasahiro Fukuzawa

Abstract

Balance of the two types of T helper cells is one of the most important factors for regulation of the immune system. This study examines the production of interleukin (IL)-4, -6, -10, -12, and interferon-gamma by peripheral blood mononuclear cells stimulated with phytohemagglutinin or Staphylococcus aureus. Sixty-one patients, including 25 with gastric and 39 with colorectal cancer, and 39 normal volunteers were entered. The production of IL-12 decreased significantly with advancing disease and was lowest in the patients with distant metastases and cachexia. Compared with normal donors, the production of interferon-gamma decreased in all categories of patients, with no difference among patient groups. Levels of Th2 cytokines, such as IL-4, IL-6, and IL-10, also showed no difference among patient groups. However, production of all these cytokines had increased by 2.5 months after sequential testing in the same cachectic patients. The authors' findings indicate that the induction of Th1 cells seems to be suppressed at a relatively early stage of disease, whereas that of Th2 cells seems to increase in the terminal stage.

References

Jan 1, 1992·Advances in Cancer Research·C J Melief
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A S SternR Chizzonite
May 31, 1995·Annals of the New York Academy of Sciences·B Golding, D E Scott
Oct 4, 1995·Journal of the National Cancer Institute·P GhoshA C Ochoa
Feb 26, 1993·Journal of Immunological Methods·T JungC Rieger
Mar 1, 1996·Immunology Today·T R Mosmann, S Sad
Oct 31, 1996·Nature·A K AbbasA Sher
May 1, 1997·International Archives of Allergy and Immunology·S RomagnaniG F Del Prete
Jun 1, 1997·Immunology Today·S Romagnani
Oct 30, 1999·Immunology and Cell Biology·M RescignoP Ricciardi-Castagnoli
Jul 6, 2000·Cancer Immunology, Immunotherapy : CII·X L ZhangM Sakurai
Aug 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·P KalińskiM L Kapsenberg
Aug 22, 2000·The Prostate·X FilellaA M Ballesta
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S Thoma-UszynskiR L Modlin

❮ Previous
Next ❯

Citations

Dec 13, 2006·Cancer Immunology, Immunotherapy : CII·Guanglin CuiJon Florholmen
Dec 4, 2010·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hironori TsujimotoKazuo Hase
Oct 12, 2012·Molecular Biology Reports·Noyko S StanilovSpaska A Stanilova
Nov 26, 2013·The Cancer Journal·Dingzhi Wang, Raymond N DuBois
Nov 29, 2012·BMC Cancer·Shinji ShimatoDavid E Anderson
Oct 31, 2012·International Journal of Molecular Sciences·Giovanni MonteleoneCarmine Stolfi
May 17, 2014·Cellular and Molecular Life Sciences : CMLS·Sebastian Foersch, Markus F Neurath
Jun 6, 2009·Seminars in Immunopathology·Maximilian J Waldner, Markus F Neurath
Apr 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Rebecca L MaywaldJason D Heaney
Jan 11, 2011·Critical Reviews in Oncology/hematology·David BlumUNKNOWN European Palliative Care Research Collaborative
Oct 4, 2006·Alimentary Pharmacology & Therapeutics·C EvansD Kumar
Jul 9, 2004·Medical Hypotheses·A Joon YunPatrick Y Lee
May 23, 2006·International Immunopharmacology·Jian ZhangZhigang Tian
May 31, 2016·Journal of Cachexia, Sarcopenia and Muscle·Masaaki KonishiStephan von Haehling
Apr 6, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ewa BienAnna Balcerska
Dec 3, 2014·The Journal of Surgical Research·Yulan WangFuhai Ji
Jan 26, 2017·Journal of Cellular Physiology·Vahid BagheriMohammad Reza Abbaszadegan
Jul 21, 2007·The American Journal of Gastroenterology·María Asunción García-GonzálezUNKNOWN Spanish Gastroenterological Association AEG
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Nobutaka SuzukiHarukuni Tokuda
Sep 1, 2018·World Journal of Gastroenterology : WJG·Daniela Cornelia LazărAdrian Goldiș
May 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Junichi EguchiHideho Okada
Jul 29, 2006·World Journal of Gastroenterology : WJG·Duangporn Thong-NgamYong Poovorawan
Feb 10, 2021·International Journal of Molecular Sciences·Aldona Kasprzak
Aug 3, 2021·Biochemical Society Transactions·Ana Sayuri Yamagata, Paula Paccielli Freire

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.